GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124 Gen1e Life SciencesHealth Oct 26 Written By Daniela Guerra Daniela Guerra
GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124 Gen1e Life SciencesHealth Oct 26 Written By Daniela Guerra Daniela Guerra
